-

Asset Value Investors (AVI) Submits Shareholder Proposals to Tokyo Radiator, a Subsidiary of Marelli, to Address the Weak Governance of the Listed-subsidiary Structure

AVI is calling on its fellow minority shareholders to express their disapproval of the board of directors’ disregard for minority interests, by voting in favour of these proposals:

  • special dividends equivalent to the past deposits to Marelli;
  • transition to a company with an audit and supervisory committee;
  • establishment of a nomination committee and a compensation committee chaired by independent outside directors;
  • abolishment of senior advisory positions (Komon and Soudanyaku);
  • introduction of stock-based compensation system for directors.

LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) today announces that it has submitted shareholder proposals to Tokyo Radiator Mfg. Co. Ltd. (TYO 7235, “Tokyo Radiator”), a subsidiary of Marelli Corporation (“Marelli”), to address conflicts of interest between the parent company and minority shareholders arising from Tokyo Radiator’s listed subsidiary structure.

AVI’s full shareholder proposals and a presentation outlining AVI’s arguments are available on the website www.assetvalueinvestors.com/tokyo-radiator/.

Joe Bauernfreund, CEO of AVI, comments: For almost five years, we have been in communication with Tokyo Radiator; Marelli, which holds approximately 40.1% of Tokyo Radiator’s shares; and Marelli’s parent company KKR, to resolve governance issues caused by Tokyo Radiator’s listed subsidiary structure and enhance Tokyo Radiator’s corporate value. We submitted shareholder proposals in June 2021 as part of our engagement activities, but, since then, Tokyo Radiator has continued to ignore our proposals and has made little effort to improve its weak governance.”

- Ends -

Note to editors

Tokyo Radiator is held in AVI Japan Opportunity Trust (‘AJOT’).

AVI is a London-based investment management company that has been investing in Japanese equities for more than 20 years. AVI was established in 1985 and has been investing in the equity markets for more than 35 years. AVI’s investment team is committed to contributing to sustainable improvements in corporate value by engaging with the management teams of its portfolio companies, with approximately JPY 78 billion invested in Japanese equities.

Contacts

Daniel Lee, Asset Value Investors
daniel.lee@assetvalueinvestors.com

Asset Value Investors
info@AssetValueInvestors.com

Asset Value Investors


Release Versions

Contacts

Daniel Lee, Asset Value Investors
daniel.lee@assetvalueinvestors.com

Asset Value Investors
info@AssetValueInvestors.com

More News From Asset Value Investors

AVI Calls for Changes at Gerresheimer

LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) has sent an open letter to the Supervisory Board of Gerresheimer AG (“Gerresheimer”) calling for it to make changes to its financial leadership. You can find the published letter here. AVI invested in Gerresheimer in 2024 and manages a 3.5% stake on behalf of institutional clients. Gerresheimer holds a valuable position in the Containment Solutions & Delivery Systems industry, with high barriers to entry and attractive long-term growth...

AVI Urges Wacom To Make Governance Changes

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (“AVI”) launches a campaign calling for Wacom Corporation (“Wacom”) to be more conscious of the capital market, and announces that AVI has submitted shareholder proposals ahead of Wacom’s upcoming AGM in June. AVI has published a detailed presentation on a dedicated website. AVI invested in Wacom in August 2021 and has sought to engage in dialogue with the company as the largest shareholder, sending letters and presentations with the aim of...

Asset Value Investors Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage With Shareholders More Constructively

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (‘AVI’) launches a campaign calling for Rohto Pharmaceutical (‘Rohto’) to focus on its core businesses rather than allocating resources to the unsuccessful regenerative medicine business, and to engage with shareholders more constructively to comply with the Tokyo Stock Exchange’s (‘TSE’) request for management that is conscious of the cost of capital and stock price. A detailed presentation can be found here. Since AVI started investing in...
Back to Newsroom